PREDICTIVE ONCOLOGY INC(NASDAQ:POAI) stock News

POAI Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Predictive Oncology Inc.

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

a month ago - By: Predictive Oncology Inc.

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

a month ago - By: Predictive Oncology Inc.

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

a month ago - By: Predictive Oncology Inc.

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

5 months ago - By: Benzinga

What's Going On With Predictive Oncology Shares Tuesday?

2 months ago - By: Predictive Oncology Inc.

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

2 months ago - By: Predictive Oncology Inc. - Mentions: LH

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

3 months ago - By: Predictive Oncology Inc.

Court Denies Renovaro Motion for an Expedited Trial in July

3 months ago - By: Predictive Oncology Inc.

Court Denies Renovaro Motion for an Expedited Trial in July

3 months ago - By: Renovaro Inc - Mentions: RENB

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

3 months ago - By: Renovaro Inc - Mentions: RENB

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

3 months ago - By: Predictive Oncology Inc.

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

3 months ago - By: Predictive Oncology Inc.

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

3 months ago - By: Predictive Oncology Inc.

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"

3 months ago - By: Predictive Oncology Inc.

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"

3 months ago - By: Predictive Oncology Inc.

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Predictive Oncology Inc.

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Zacks Investment Research - Mentions: SENS

Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

4 months ago - By: Predictive Oncology Inc.

Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs

3 months ago - By: FN Media Group LLC - Mentions: AVAI TDOC TEM GEHC

Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies

4 months ago - By: Benzinga - Mentions: PIII PTIX CPHI BCLI ...

12 Health Care Stocks Moving In Friday's After-Market Session

4 months ago - By: Renovaro Inc - Mentions: RENB

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

4 months ago - By: Predictive Oncology Inc.

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

3 months ago - By: FN Media Group LLC - Mentions: AVAI RXRX TEM ADMA

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

4 months ago - By: Predictive Oncology Inc.

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

5 months ago - By: Predictive Oncology Inc.

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

5 months ago - By: Predictive Oncology Inc.

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

5 months ago - By: Predictive Oncology Inc.

PREDICTIVE ONCOLOGY INC (POAI) Stock News

POAI Latest News, Press Relases and Analysis

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

What's Going On With Predictive Oncology Shares Tuesday?

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

Court Denies Renovaro Motion for an Expedited Trial in July

Court Denies Renovaro Motion for an Expedited Trial in July

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs

Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies

12 Health Care Stocks Moving In Friday's After-Market Session

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries